Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
AstraZeneca
Dow
Express Scripts
McKesson

Last Updated: June 28, 2022

CHILDREN'S MOTRIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Children's Motrin, and when can generic versions of Children's Motrin launch?

Children's Motrin is a drug marketed by J And J Consumer Inc and is included in four NDAs.

The generic ingredient in CHILDREN'S MOTRIN is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.

US Patents and Regulatory Information for CHILDREN'S MOTRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc CHILDREN'S MOTRIN ibuprofen SUSPENSION/DROPS;ORAL 020603-001 Jun 10, 1996 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc CHILDREN'S MOTRIN COLD ibuprofen; pseudoephedrine hydrochloride SUSPENSION;ORAL 021128-001 Aug 1, 2000 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc CHILDREN'S MOTRIN ibuprofen SUSPENSION;ORAL 020516-001 Jun 16, 1995 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
J And J Consumer Inc CHILDREN'S MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020601-001 Nov 15, 1996 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CHILDREN'S MOTRIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc CHILDREN'S MOTRIN ibuprofen SUSPENSION/DROPS;ORAL 020603-001 Jun 10, 1996 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc CHILDREN'S MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020601-001 Nov 15, 1996 See Plans and Pricing See Plans and Pricing
J And J Consumer Inc CHILDREN'S MOTRIN ibuprofen SUSPENSION;ORAL 020516-001 Jun 16, 1995 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

EU/EMA Drug Approvals for CHILDREN'S MOTRIN

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Recordati Rare Diseases Pedea ibuprofen EMEA/H/C/000549
Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age.
Authorised no no no 2004-07-28
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

International Patents for CHILDREN'S MOTRIN

See the table below for patents covering CHILDREN'S MOTRIN around the world.

Country Patent Number Title Estimated Expiration
South Korea 0161969 See Plans and Pricing
Ireland 69042 Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets See Plans and Pricing
Portugal 94504 PROCESSO PARA A PREPARACAO DE COMPOSICOES FARMACEUTICAS AQUOSAS EM SUSPENSAO PARA INGREDIENTES ACTIVOS SUBSTANCIALMENTE INSOLUVEIS EM AGUA See Plans and Pricing
Israel 94887 Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives See Plans and Pricing
European Patent Office 0405930 Suspension pharmaceutique aqueuse pour des agents actifs pharmaceutiques essentiellement insolubles dans l'eau. (Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives.) See Plans and Pricing
Ireland 902823 See Plans and Pricing
Ireland 902332 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
McKinsey
Merck
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.